Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald W Cockcroft

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 5, 2014
A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responsesGail M Gauvreau, Louis-Philippe Boulet, Richard Leigh, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthmaPaul M O'Byrne, Just van der Linde, Donald W Cockcroft, et al.
The European Respiratory Journal|January 28, 2022
Allergen provocation tests in respiratory research: building on 50 years of experienceGail M Gauvreau, Beth E Davis, Guy Scadding, et al.
The European Respiratory Journal|May 3, 2017
ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge testsAllan L Coates, Jack Wanger, Donald W Cockcroft, et al.
The European Respiratory Journal|October 27, 2018
ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testingTeal S Hallstrand, Joerg D Leuppi, Guy Joos, et al.
Science Translational Medicine|July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE productionGail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
The European Respiratory Journal|February 23, 2023
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthmaGail M Gauvreau, Jens M Hohlfeld, J Mark FitzGerald, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2010
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthmaGail M Gauvreau, Louis-Philippe Boulet, Donald W Cockcroft, et al.
ERJ Open Research|March 9, 2022
International consensus on lung function testing during the COVID-19 pandemic and beyondAisling McGowan, Pierantonio Laveneziana, Sam Bayat, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2016
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responsesGail M Gauvreau, Jonathan P Arm, Louis-Philippe Boulet, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
American Journal of Respiratory and Critical Care Medicine|December 5, 2014
A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responsesGail M Gauvreau, Louis-Philippe Boulet, Richard Leigh, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthmaPaul M O'Byrne, Just van der Linde, Donald W Cockcroft, et al.
The European Respiratory Journal|January 28, 2022
Allergen provocation tests in respiratory research: building on 50 years of experienceGail M Gauvreau, Beth E Davis, Guy Scadding, et al.
The European Respiratory Journal|May 3, 2017
ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge testsAllan L Coates, Jack Wanger, Donald W Cockcroft, et al.
The European Respiratory Journal|October 27, 2018
ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testingTeal S Hallstrand, Joerg D Leuppi, Guy Joos, et al.
Science Translational Medicine|July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE productionGail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
The European Respiratory Journal|February 23, 2023
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthmaGail M Gauvreau, Jens M Hohlfeld, J Mark FitzGerald, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2010
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthmaGail M Gauvreau, Louis-Philippe Boulet, Donald W Cockcroft, et al.
ERJ Open Research|March 9, 2022
International consensus on lung function testing during the COVID-19 pandemic and beyondAisling McGowan, Pierantonio Laveneziana, Sam Bayat, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2016
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responsesGail M Gauvreau, Jonathan P Arm, Louis-Philippe Boulet, et al.
Pageof 14